Efficacy of pramipexole combined with levodopa for Parkinson’s disease treatment and their effects on QOL and serum TNF-α levels

PURPOSE: To investigate the efficacy of combining the dopamine receptor agonist pramipexole with levodopa for Parkinson’s disease (PD) treatment and to measure their effects on quality of life and tumor necrosis factor (TNF)-α levels in PD patients. BASIC PROCEDURE: In total, 160 PD patients who wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jinzhong, Hong, Wei, Yang, Zhilong, Ding, Jian, Ren, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401155/
https://www.ncbi.nlm.nih.gov/pubmed/32735501
http://dx.doi.org/10.1177/0300060520922449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401155/
https://www.ncbi.nlm.nih.gov/pubmed/32735501
http://dx.doi.org/10.1177/0300060520922449

Ejemplares similares